Displaying drugs 14526 - 14550 of 15307 in total
Lusvertikimab
Investigational
GXC-301
Investigational
Iltamiocel
Investigational
Propionibacterium acnes
Investigational
Lactobacillus crispatus strain CTV-05
Investigational
5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine
Experimental
1h-Benoximidazole-2-Carboxylic Acid
Experimental
SB220025
Experimental
1-Naphthyl-L-alanine
Experimental
3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine
Experimental
Ethadione
Experimental
Reproxalap
Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.
Investigational
Matched Description: … Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and …
3-hydroxyisoxazole-4-carboxylic acid
Experimental
3'-Deazo-Thiamin Diphosphate
Experimental
4-Sulfonamide-[1-(4-Aminobutane)]Benzamide
Experimental
Cambendazole
Experimental
Vet approved
Xylose-derived lactam oxime
Experimental
Displaying drugs 14526 - 14550 of 15307 in total